A new nerve-illuminating tool has been developed by researchers and they claim it makes nerves stand out from other tissue, lighting it up to help surgeons avoid accidentally injuring nerves and identify nerves in need of repair.
A press conference for the launch of the Ddu Credit Verification service was successfully held at Shenzhenair International Hotel, HallⅠin Shenzhen, China on August 18, 2017.
NeoSync has announced the completion of its Series D financing round, which included investment from Valiance Life Science Investments, as well as its original investor base totaling $13m.
Camber Spine Technologies' Spira open matrix anterior lumbar interbody fusion device won FDA clearance from the FDA.
Being set to supply ingredients for around 400 million vaccines a year, a new £44 million aluminium salts facilityhas been officially opened by GlaxoSmithKline in Montrose, Scotland.
The 27th Florida International Medical Exhibition (FIME) was grandly held in Orlando, USA from August 8th to August 10th, 2017. As the leading global pharmaceutical and medical device B2B online platform, Ddu, attended the exhibition along with products of high priority members, becoming one of the most popular brands at FIME.
New treatments for neurodegenerative disease and motion disability will be developed by a research collaboration between digital healthcare solutions provider MC10 and US-based rehabilitation research hospital, Shirley Ryan AbilityLab.
Vascular focused device developer VentureMed said today it raised $15 million in a Series B round.
In support of the project in adopting Atlas Genetic's io rapid diagnostic platform into UK sexual health clinics, Innovative UK has awarded them a grant of £2 million.
Early asymptomatic nasopharyngeal carcinoma (NPC) will possibly be detectable by plasma Epstein-Barr virus (EBV) DNA analysis, according to a new study carried out by the Chinese University of Hong Kong (CUHK).
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.